KIGALI, March 13 (Xinhua) -- BioNTech, a German biotechnology company based in Mainz, on Monday delivered containers of the first BioNTainer- facilities equipped to manufacture a range of mRNA-based vaccines at its plant in Rwanda.
Six BioNTainers, each consisting of drug substances and formula capable of producing 50 million to 100 million vaccine doses a year were received by Rwandan Minister of Health Sabin Nsanzimana, and Sierk Poetting, the chief operating officer of BioNTech.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
